Unichem Laboratories · NSE: UNICHEMLAB · BSE: 506690
Q4 FY25 results · Jan–Mar 2025
Unichem Laboratories reported revenue from operations of ₹587.18 crore (up 36.0% from Q4 FY24) and net profit of ₹52.97 crore for Q4 FY25 (Jan–Mar 2025), on a consolidated basis.
| Item | Q4 FY25 | Q4 FY24 | YoY | Q3 FY25 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 587.18 | 431.70 | +36.0% | 533.09 | +10.1% |
| Other income | 9.25 | 6.15 | +50.3% | 13.62 | −32.1% |
| Total income | 596.43 | 437.85 | +36.2% | 546.71 | +9.1% |
| Profit before tax | 57.80 | (125.87) | Turned profit | 61.85 | −6.5% |
| Net profit for the period | 52.97 | (129.31) | Turned profit | 57.85 | −8.4% |
| EPS, basic (₹) | 7.52 | (18.37) | Turned profit | 8.22 | −8.5% |
| Net margin (%) | 9.0 | -30.0 | 10.9 |
| Item | Q4 FY25 | Q4 FY24 | YoY | Q3 FY25 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 461.24 | 399.24 | +15.5% | 447.83 | +3.0% |
| Other income | 6.05 | 7.04 | −14.0% | 18.93 | −68.0% |
| Total income | 467.29 | 406.28 | +15.0% | 466.76 | +0.1% |
| Profit before tax | 56.03 | (114.97) | Turned profit | 61.80 | −9.3% |
| Net profit for the period | 51.22 | (114.97) | Turned profit | 46.89 | +9.2% |
| EPS, basic (₹) | 7.28 | (16.33) | Turned profit | 6.66 | +9.3% |
| Net margin (%) | 11.1 | -28.8 | 10.5 |
Consolidated
- Filed with BSE
- 22 May 2025, 17:17 IST
- Board meeting
- 22 May 2025
- Period
- 01 Jan 2025 to 31 Mar 2025
- Review status
- Unaudited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 22 May 2025, 17:17 IST
- Board meeting
- 22 May 2025
- Period
- 01 Jan 2025 to 31 Mar 2025
- Review status
- Unaudited
- Source
- XBRL filing on BSE